Depreciation in USD of Centessa Pharmaceuticals plc from Q2 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Centessa Pharmaceuticals plc quarterly/annual Depreciation history and change rate from Q2 2021 to 2024.
  • Centessa Pharmaceuticals plc Depreciation for the quarter ending March 31, 2024 was $86K, a 132% increase year-over-year.
  • Centessa Pharmaceuticals plc annual Depreciation for 2024 was $300K, unchanged from 2023.
  • Centessa Pharmaceuticals plc annual Depreciation for 2023 was $300K, a 129% increase from 2022.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Centessa Pharmaceuticals plc Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $86K +$49K +132% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $37K +$9K +32.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $28K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $15.7K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $5.43K Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16

Centessa Pharmaceuticals plc Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $300K $0 0% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $300K +$169K +129% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $131K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.